| 原料品名 | SITAGLIPTIN PHOSPHATE MONOHYDRATE USP |
|---|---|
| 原料中文名称 | 磷酸西格列汀 |
| 英文别名 | 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)Butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazinephosphatemonohydrate; Sitagliptin phosphate monohydrate; Sitagliptin phosphate for research |
| 中文别名 | 磷酸西格列汀无水物;磷酸西格列汀一水物;磷酸西他列汀;磷酸西格列汀;磷酸西他司汀;磷酸西他列汀一水;MK-0432 PHOSPHATE MONOHYDRATE;磷酸西他列汀,西他列汀中间体;磷酸西他列汀,西格列汀中间体 |
| 化学名称 | (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid;hydrate |
| 分子式 | C16H20F6N5O6P |
| 分子量 | 523.33 |
| CAS号 | 654671-77-9 |
| EINECS编号 | 暂无权限 |
| 结构式图片 | 暂无权限 |
| 美国DMF登记 | 暂无权限 |
供应商信息
| 企业名称 | LAURUS LABS LTD |
|---|---|
| 地址 | 21,Jn Pharma City,Parawada,Visakhapatnam 531021,Ap,India |
| 国家/地区 | 印度 |
| 公司官网 | 暂无权限 |
| 公司联系电话 | 暂无权限 |
| 公司简介 | We develop innovative medicines that greatly improve health outcomes for patients with an unremitting focus on quality and affordability. We work with all the top 10 generic pharmaceutical companies in the world. We sell our APIs in 56 countries. Our major focus areas include anti-retroviral, Hepatitis C and Oncology drugs. Continuous innovation is the lifeblood of our business. Therefore, we undertake dedicated R&D in areas that have significant growth potential. We filed 257 patents in which we own 116 patents. We have commercialised 60+ products since inception across four distinct business units: Generics API, Generics FDF, Ingredients and Synthesis. |
| 备注 | 若未能联系上供应商，可在药智通发布求购信息（https://s.yaozh.com/Purchase/release），或联系药智通客服17318480790（微信同号） |
扩展信息
